$Symbotic (SYM.US)$ this company is going to be hit with multiple class action lawsuits I suspect by Friday you will see an announcement from several of the top law firms in the United States that will be going after this company and going after blood. The CEO is speak on a conference call  post earnings wear your bragging and gloating about your success this quarter and then gave forward guidance that was complete and utter bullshit lies.  you answered questions to analysts who base their invest...

$Symbotic (SYM.US)$ look at these scumbag officers look at the amount of shares they have sold after the earnings in the stock spiked. 57,000 shares for one person.. and look at the others they all registered and sold on the spike which is bullshit fraud everyone of these officers of the company needs to have 100% of their proceeds reclaimed. everyone said around the table and knew exactly what the hell was going on with their financials and they profiteered as a result of this fraud. 100% of all...

$GameStop (GME.US)$ $AMC Entertainment (AMC.US)$ Cramer said we should sell. Guess that’s it ladies and gentlemen.

Hello everyone and welcome back to moomoo. I'm options explorer.
In the upcoming weeks, we are going to see a flurry of earnings reports in the U.S. stock market, including notable appearances from companies like $Coca-Cola (KO.US)$， $Apple (AAPL.US)$,and $Amazon (AMZN.US)$.
After a company's earnings report, stock prices often experience high volatility.
For options traders, volatility often presents opportunities; hig...

$Ginkgo Bioworks (DNA.US)$Ark invest. just add more $198.6 millions, best for all.

$CRISPR Therapeutics (CRSP.US)$ won U.K. authorization for its treatment of sickle cell anemia.
Casgevy is now before the FDA and could offer a lifetime cure.
$Vertex Pharmaceuticals (VRTX.US)$ was CRISPR’s partner in development.
The Bottom Line on CRSP Stock
The U.K. decision won’t have a huge financial impact, but it could be the first of many. CRISPR has treatments for cancer, diabetes, and heart disease in its pipeline. The FDA deci...